Literature DB >> 27276918

Amlodipine has a preventive effect on temporal left ventricular hypokinesia after emotional stress compared with an angiotensin II receptor blocker.

Fuminobu Ishikura1, Yuri Takano2, Takashi Ueyama3.   

Abstract

PURPOSE: We previously reported that α- and β-blockers protected against emotional stress-induced cardiac dysfunction, but the protective effects of other antihypertensive drugs is unknown. The purpose of this study is to evaluate the ability of a calcium channel blocker, amlodipine, to prevent temporal left ventricular hypokinesia after emotional stress compared with an angiotensin II receptor blocker, olmesartan medoxomil.
METHODS: Rats premedicated with amlodipine (0.2 mg/kg), olmesartan (0.8 mg/kg), or vehicle were restrained for 30 min (immobilization stress: IMO) to reproduce emotional stress and then anesthetized to release stress. We measured the fractional area change (FAC) using echocardiography (SONOS5500) with a s12 probe (frequency 5-12 MHz, frame rate 120 Hz) and blood pressure and heart rate at the end of IMO and every 10 for 60 min after IMO.
RESULTS: During IMO, FAC in the amlodipine or the olmesartan group was as high as that in the vehicle group. At 20 min after IMO, FAC in the amlodipine group was significantly higher than in the other two groups (84 ± 8 vs. 60 ± 7 or 68 ± 15 %, p < 0.05). During IMO, blood pressure in the amlodipine or the olmesartan group was significantly lower than with vehicle (119 ± 6 and 110 ± 7 vs. 124 ± 5 mmHg, p < 0.05). After IMO, blood pressure in the olmesartan group was significantly lower than in the other two groups.
CONCLUSION: Acute administration of amlodipine could prevent a sudden drop in cardiac function after acute stress like IMO, but olmesartan did not. Amlodipine might have a protective effect on temporal left ventricular hypokinesia after emotional stress, which might not be related to decreased blood pressure.

Entities:  

Keywords:  Calcium channel blocker; Left ventricular dysfunction; Mental stress; Takotsubo (ampulla) cardiomyopathy

Year:  2012        PMID: 27276918     DOI: 10.1007/s10396-012-0392-5

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  22 in total

1.  Estrogen attenuates the emotional stress-induced cardiac responses in the animal model of Tako-tsubo (Ampulla) cardiomyopathy.

Authors:  Takashi Ueyama; Takuzo Hano; Ken Kasamatsu; Katsuhiro Yamamoto; Yoshihiro Tsuruo; Ichiro Nishio
Journal:  J Cardiovasc Pharmacol       Date:  2003-12       Impact factor: 3.105

2.  Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy.

Authors:  Holger M Nef; Helge Möllmann; Pirmin Hilpert; Christian Troidl; Sandra Voss; Andreas Rolf; Christopher B Behrens; Michael Weber; Christian W Hamm; Albrecht Elsässer
Journal:  Eur J Heart Fail       Date:  2009-08       Impact factor: 15.534

3.  Azelnidipine, unique calcium channel blocker could prevent stress-induced cardiac dysfunction like α·β blocker.

Authors:  Yuri Takano; Takashi Ueyama; Fuminobu Ishikura
Journal:  J Cardiol       Date:  2012-03-20       Impact factor: 3.159

4.  Chronic estrogen supplementation following ovariectomy improves the emotional stress-induced cardiovascular responses by indirect action on the nervous system and by direct action on the heart.

Authors:  Takashi Ueyama; Fuminobu Ishikura; Akiko Matsuda; Toshihiko Asanuma; Kazuki Ueda; Masao Ichinose; Ken Kasamatsu; Takuzo Hano; Takashi Akasaka; Yoshihiro Tsuruo; Keiko Morimoto; Shintaro Beppu
Journal:  Circ J       Date:  2007-04       Impact factor: 2.993

5.  Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction.

Authors:  Satoshi Kurisu; Hikaru Sato; Takuji Kawagoe; Masaharu Ishihara; Yuji Shimatani; Kenji Nishioka; Yasuyuki Kono; Takashi Umemura; Suji Nakamura
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

6.  Increased incidence of transient left ventricular apical ballooning (so-called 'Takotsubo' cardiomyopathy) after the mid-Niigata Prefecture earthquake.

Authors:  Masahito Sato; Satoru Fujita; Atushi Saito; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Junji Ishiguro; Masaaki Okabe; Yuichi Nakamura; Tsuneo Nagai; Hiroshi Watanabe; Makoto Kodama; Yoshifusa Aizawa
Journal:  Circ J       Date:  2006-08       Impact factor: 2.993

7.  Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.

Authors:  Kazuhiko Nishigaki; Yukiko Inoue; Yoshio Yamanouchi; Yoshihiro Fukumoto; Satoshi Yasuda; Shozo Sueda; Hidenori Urata; Hiroaki Shimokawa; Shinya Minatoguchi
Journal:  Circ J       Date:  2010-07-21       Impact factor: 2.993

Review 8.  Takotsubo cardiomyopathy presenting as multivessel coronary spasm syndrome: case report and review of the literature.

Authors:  Vicky Sansen; Germain Holvoet
Journal:  Acta Cardiol       Date:  2007-10       Impact factor: 1.718

9.  Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: a possible animal model of 'tako-tsubo' cardiomyopathy.

Authors:  Takashi Ueyama; Ken Kasamatsu; Takuzo Hano; Katsuhiro Yamamoto; Yoshihiro Tsuruo; Ichiro Nishio
Journal:  Circ J       Date:  2002-07       Impact factor: 2.993

Review 10.  Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system.

Authors:  R Kvetnanský; K Pacák; K Fukuhara; E Viskupic; B Hiremagalur; B Nankova; D S Goldstein; E L Sabban; I J Kopin
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

View more
  1 in total

Review 1.  Takotsubo Syndrome: Translational Implications and Pathomechanisms.

Authors:  Xuehui Fan; Guoqiang Yang; Jacqueline Kowitz; Ibrahim Akin; Xiaobo Zhou; Ibrahim El-Battrawy
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.